prime DX: A New Era in Personalized Cancer Treatment!
The prime DX new technology for tumor molecular profiling is compatible with both FFPE and PLASMA.
read moreThe prime DX new technology for tumor molecular profiling is compatible with both FFPE and PLASMA.
read moreWe are proud to be part of the Baltic Congress of Oncologists and Surgeons 2023 Sept. 7 - Sept. 9.
Our booth is no 6.
Feel free to visit us!
read more
The study by the Genekor Scientific Team on "The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine" was published in the Journal of the Neurological Sciences.
read moreMolecular Prognosis of Recurrence & Prediction of Chemotherapy Benefit in Colon & Rectal Cancer.
read more
The study by the Genekor Scientific Team on "Polygenic Risk Score in a cohort of 105 Breast Cancer patients previously tested with a multi gene panel for hereditary cancer" was presented at the San Antonio Breast Cancer Symposium 2022 in the form of a Poster.
read moreThrough a two-year program, patients with suspected symptoms from Greece, Romania, Poland, the Czech Republic, Hungary, Ukraine and Israel gain free access to genetic testing with the advanced NGS (New Generation Sequencing) method, which ensures fast and reliable diagnosis of rare diseases.
read more
Another important study by the Genekor Scientific Team on “Next Generation Sequencing (NGS) for the identification of PARP inhibitors’ predictive biomarkers” was presented by Dr. Floros Ir. Theofanis (Oncologist Pathologist, Military Doctor P.N. - Director, 5th Oncology Clinic of Metropolitan General Hospital) at ESMO CONGRESS 2022 in the form of a Poster.
read moreThe study by the Genekor Scientific Team on "Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes" was presented at ESMO CONGRESS 2022 in the form of a Poster by Doctors Ziogas Dimitrios (Pathologist-Oncologist A Oncology Clinic Laiko Athens General Hospital) and Giassas Stylianos (Pathologist-Oncologist, Director B, Oncology Clinic, Iasso Hospital).
read more